Mainolfi Nello 的 Form 4 申報
Kymera Therapeutics, Inc.（KYMR），2021/10/12 申報
- 申報編號
- 0000899243-21-039857
- 申報時間
- 2021/10/12
- 交易日
- 2021/10/8-10/11
- 申報延遲
- 4 天
- 10b5-1 計畫
- 表單沒有這欄（2023 年以前）
這份申報列了 10 筆非衍生性交易、2 筆衍生性交易。公開市場賣出合計 $270.5 萬。交易後 4 天申報。
申報人
一份 Form 4 可以有好幾位申報人，例如本人與他控制的基金。各交易表上顯示的是第一位。
| 申報人 | 與公司的關係 |
|---|---|
| Mainolfi NelloCIK 0001821189 | 董事、高階主管（執行長） |
非衍生性證券（表 I）
普通股等股票的取得與處分，每一列是申報上的一筆。
| 交易日 | 證券 | 交易 | 股數 | 價格 | 金額 | 交易後持股 | 持有方式 | 旗標 |
|---|---|---|---|---|---|---|---|---|
| 2021/10/8 | Common Stock | M行使選擇權取得 | +41,544 | $2.08 | +$86,411.52 | 505,743 | 直接 | |
| 2021/10/8 | Common Stock | S賣出處分 | −21,236 | $55.56F2 | −$1,179,872.16 | 484,507 | 直接 | |
| 2021/10/8 | Common Stock | S賣出處分 | −9,369 | $56.82F3 | −$532,346.58 | 475,138 | 直接 | |
| 2021/10/8 | Common Stock | S賣出處分 | −2,078 | $57.29F4 | −$119,048.62 | 473,060 | 直接 | |
| 2021/10/8 | Common Stock | S賣出處分 | −7,920 | $59.28F5 | −$469,497.6 | 465,140 | 直接 | |
| 2021/10/8 | Common Stock | S賣出處分 | −670 | $60.32F6 | −$40,414.4 | 464,470 | 直接 | |
| 2021/10/8 | Common Stock | S賣出處分 | −271 | $61.87 | −$16,766.77 | 464,199 | 直接 | |
| 2021/10/11 | Common Stock | M行使選擇權取得 | +6,456 | $2.08 | +$13,428.48 | 470,655 | 直接 | |
| 2021/10/11 | Common Stock | S賣出處分 | −5,712 | $53.58F7 | −$306,048.96 | 464,943 | 直接 | |
| 2021/10/11 | Common Stock | S賣出處分 | −744 | $54.50F8 | −$40,548 | 464,199 | 直接 |
衍生性證券（表 II）
選擇權、認股權證、限制型股票單位等。股數是標的股票的股數；單價與金額是衍生證券本身的價格，交易後持有是衍生證券的單位數。
| 交易日 | 證券 | 交易 | 標的股數 | 單價 | 金額 | 交易後持有 | 持有方式 | 旗標 |
|---|---|---|---|---|---|---|---|---|
| 2021/10/8 | Common Stock | M行使選擇權處分 | −41,544 | $0.00 | $0 | 35,181 | 直接 | |
| 2021/10/11 | Common Stock | M行使選擇權處分 | −6,456 | $0.00 | $0 | 28,725 | 直接 |
附註與備註
本站收錄交易價格引用的附註、修正申報（Form 4/A）的全部附註，以及申報的備註。其他附註，例如間接持有的方式、交易計畫的細節，請看 SEC EDGAR 上的原文。
- F2
The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $55.10 to $56.09. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request.
表 I 有 1 筆交易的價格引用這則附註。
- F3
The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $56.19 to $57.185. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request.
表 I 有 1 筆交易的價格引用這則附註。
- F4
The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $57.20 to $58.14. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request.
表 I 有 1 筆交易的價格引用這則附註。
- F5
The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $58.90 to $59.81. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request.
表 I 有 1 筆交易的價格引用這則附註。
- F6
The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $59.91 to $60.61. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request.
表 I 有 1 筆交易的價格引用這則附註。
- F7
The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $53.19 to $54.16. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request.
表 I 有 1 筆交易的價格引用這則附註。
- F8
The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $54.28 to $54.60. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request.
表 I 有 1 筆交易的價格引用這則附註。